Citadel Advisors
ELGX

Citadel Advisors’s Endologix Inc ELGX Stock Holding History

Citadel Advisors’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,030
Closed -$285K – 10017
2018
Q2 		$285K Buy
+5,030
New +$255K ﹤0.01% 7304

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors's ELGX Position: Q1 2019 in Review

Citadel Advisors sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 85,148 shares — an estimated $610K sold.

Citadel Advisors first reported a position in ELGX in Q2 2013 and held it in 18 quarters. The position peaked at $15.1M in Q3 2014. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

  • Citadel Advisors reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
  • Citadel Advisors sold 85,148 Endologix Inc shares in Q1 2019, an estimated $610K.
  • Citadel Advisors first reported a position in Endologix Inc in Q2 2013 and held it in 18 quarters.
  • Citadel Advisors's Endologix Inc position peaked at $15.1M in Q3 2014.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.